(Q50758028)
Statements
Three-year evaluation of neuropsychiatric adverse events in the MONET trial of darunavir/ritonavir, with or without nucleoside analogues. (English)
1 reference
A Winston
1 reference
C Moecklinghoff
1 reference
A Hill
1 reference
1 March 2012
1 reference
23
1 reference
3
1 reference
225-226
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference